Guiding Appropriate Cancer Treatment with Molecular Residual Disease Testing - Episode 7

INSPIRE and IMvigor011 Trials

Jason Starr, DO, discusses the INSPIRE and IMvigor011 studies that focused on the use of ctDNA in MRD.